Go to deals
Healthcare

Optibiotix Health has successfully raised US$1.3 million though a placing of new shares

Optibiotix Health Plc has completed a fundraising to continue the commercialization of its products with corporate and large retail partners, with a particular focus on the company’s SweetBiotix©.

OptiBiotix Health is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. With an established pipeline of microbiome modulators, the OptiBiotix team is working in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles and diabetes.

Oaklins Cavendish’s sister firm finnCap, based in the UK, advised Optibiotix Health on its equity fundraising.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Laptaria cu Caimac has completed an IPO
Food & Beverage

Laptaria cu Caimac has completed an IPO

Laptaria cu Caimac has raised US$5 million through a private placement of shares on the ATS Market of BSE. The funds will be used for the development of the factory, namely, the construction of a bottle and jar washing station, utility systems and packaging storage.

Learn more
Alexandria Pankkiiriliike Oyj has raised US$9.7m in the course of its IPO on NASDAQ First North Finland
Financial Services

Alexandria Pankkiiriliike Oyj has raised US$9.7m in the course of its IPO on NASDAQ First North Finland

Alexandria Pankkiiriliike Oyj (Alexandria) has raised US$9.7 million in the course of its IPO.

Learn more
Crimson Tide has completed a primary placing and secondary sell-down
TMT

Crimson Tide has completed a primary placing and secondary sell-down

Crimson Tide Plc has raised funds to invest in further developing its core product, in a new product aimed at micro/nano businesses and in marketing capabilities.

Learn more